Company Filing History:
Years Active: 1989-1995
Title: The Innovations of Detlef Piechaczek
Introduction
Detlef Piechaczek is a notable inventor based in Munster, Germany. He has made significant contributions to the field of immunology, particularly through his innovative patent work. With a total of five patents to his name, Piechaczek has focused on developing advanced immunoglobulin preparations for medical applications.
Latest Patents
Among his latest patents is the development of unmodified intravenously administered immunoglobulin preparations. This preparation contains more than 5% of its total immunoglobulin by weight consisting of IgM and/or more than 10% of its total immunoglobulin of IgA, exhibiting low anticomplementary activity. The method of preparing this immunoglobulin involves anion-exchange chromatography. Another significant patent is for an intravenously administrable polyclonal immunoglobulin preparation aimed at treating and preventing bacterial infections. This preparation contains at least 50% by weight of IgM and is designed to be stable in aqueous solution while being free of viruses. The source material for this preparation is an immunoglobulin-containing fraction derived from human, animal, or bacterial sources, which undergoes various treatments to ensure its efficacy and safety.
Career Highlights
Detlef Piechaczek has built a successful career at Biotest Pharma GmbH, where he has been instrumental in advancing immunological therapies. His work has not only contributed to the scientific community but has also had a significant impact on patient care through innovative treatment options.
Collaborations
Throughout his career, Piechaczek has collaborated with esteemed colleagues such as Dieter Rudnick and Wolfgang Moller. These collaborations have fostered a productive environment for research and development in the field of immunology.
Conclusion
Detlef Piechaczek's contributions to immunology through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches to immunoglobulin preparations continue to influence medical practices and improve patient outcomes.